Trial Profile
Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 20 Jun 2014
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Adverse reactions; Registrational
- Sponsors Revance Therapeutics
- 29 Jan 2014 New trial record